Login to Your Account



Start-up Allecra Gets $20M for Antibiotic Development

By Cormac Sheridan
Staff Writer

Thursday, April 18, 2013
Allecra Therapeutics GmbH, a Franco-German start-up raised €15 million (US$19.6 million) in a Series A round to take two antibiotic development programs into the clinic and through clinical proof of concept.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription